BIOTECHNICS DANMARK A/S: Financial statements 2017
CVR: 29822034
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOTECHNICS DANMARK A/S (CVR 29822034) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -277,270 and a net result of DKK -223,155 compared with DKK -49,128 the year before. Equity in the 2017 report amounted to DKK 190,139. The solvency ratio was 46.3%.
- Gross Profit
- DKK -277,270
- Profit/Loss
- DKK -223,155
- Equity
- DKK 190,139
- Total Assets
- DKK 410,280
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -277 t. | -223 t. | 190 t. | - |
| 2016 | - | -78 t. | -49 t. | 413 t. | - |
| 2015 | - | - | 0 | 0 | - |
| 2014 | - | - | 0 | 0 | - |
| 2013 | - | - | 0 | 0 | - |
Official annual report
Keep an eye on BIOTECHNICS DANMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 6, 2017, BHA STATSAUTORISERET REVISION APS has been appointed auditor of BIOTECHNICS DANMARK A/S.
As of October 6, 2017, Kreston CM Statsautoriseret Revisions interessentskab has stepped down as auditor of BIOTECHNICS DANMARK A/S.
BIOTECHNICS DANMARK A/S has published its annual report for 2016. Gross profit came to DKK -77,738, and the net result was DKK -49,128.
As of June 11, 2017, Allan Pettersson has joined the board of directors of BIOTECHNICS DANMARK A/S.
As of June 11, 2017, Philip Carsten Filipsen has joined the board of directors of BIOTECHNICS DANMARK A/S.
As of June 11, 2017, Leif Peter Dige has left the board of directors of BIOTECHNICS DANMARK A/S.
As of June 11, 2017, Jakob Dige has left the board of directors of BIOTECHNICS DANMARK A/S.
About BIOTECHNICS DANMARK A/S
BIOTECHNICS DANMARK A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Anden teknisk rådgivning. The management consists of Jonas Jacob Husmer. The board consists of Flemming Heegaard (chair), Jonas Jacob Husmer and Philip Broberg Falk. The company is owned by Biosystems Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 2,219,527 and a net result of DKK 276,093 compared with DKK -21,609 the year before. Equity in the 2025 report amounted to DKK 854,483.